Add 2 More Reports For 20% off

Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Hormonal Contraceptive Market Outlook

The global hormonal contraceptive market size was valued at USD 17.49 billion in 2023, driven by the high rates of efficacy and reliability of hormonal contraceptives and the innovations in the market. The market is estimated to grow at a CAGR of 4.1% during the forecast period 2024-2032 to attain a value of USD 25.11 billion by 2032.

Global Hormonal Contraceptive Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

North America to Provide Significant Growth Opportunities to the Hormonal Contraceptive Industry

Geographically, North America is a significant region contributing to the growth of the hormonal contraceptive industry globally. The market growth in the region can be attributed to the increased awareness among people regarding hormonal contraceptives and their benefits. Hormonal contraceptives help prevent unwanted pregnancy.  These are reliable and also provide relief from period pain and lead to lighter periods. They can be taken as pills, or can be injected, or inserted under the skin. Hormonal birth control also has some long-term advantages like it reduces the risk of uterus cancer and also reduces the risk of ovary cysts. These factors are driving the demand for hormonal contraceptives in the region. In addition, the availability of advanced healthcare infrastructure and clinical facilities are also enhancing the regional market growth.

Hormonal Contraceptive: Market Segmentation

Hormonal contraceptive refers to a type of birth control method that targets the endocrine system to prevent pregnancy. Hormonal contraceptives help prevent pregnancy by blocking the release of eggs from the ovaries. They contain estrogen and progesterone, or progesterone only, and may be taken by mouth, injected, or inserted under the skin. They influence hormone levels in women and prevent mature eggs from being released. However, they can have side effects such as headaches, nausea, mood swings, and other issues.

Global Hormonal Contraceptive Market By method

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Based on method, the market can be segmented into:

  • Pills
  • Intrauterine Devices (IUD)
  • Injectable
  • Vaginal Ring
  • Implant
  • Patch

The EMR report looks into the regional markets of hormonal contraceptive like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Global Hormonal Contraceptive Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Various Benefits of Hormonal Contraceptives and the Improving Healthcare Facilities to Bolster the Global Market for Hormonal Contraceptive

The high rates of efficacy and reliability of hormonal contraceptives and the innovations in the market are the key drivers for the hormonal contraceptive industry growth globally. Hormonal contraceptives can also relieve the symptoms of premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD). Furthermore, hormonal birth control methods allow women to skip their periods by taking pills, contraceptive coils, or others, and, thus, help avoid menstrual migraines. They also reduce the risk of anaemia, as some women experience high bleeding during their periods, which may lead to fatigue and weakness. These factors are driving the growth of the industry. In addition, the growing research and development activities in the pharmaceutical sector and the improving healthcare infrastructure particularly in emerging economies are expected to further propel the market forward.

Key Industry Players in the Global Hormonal Contraceptive Market

The report presents a detailed analysis of the following key players in the global hormonal contraceptive market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions.

  • Allergan Inc.
  • Pfizer Inc.
  • Bayer AG
  • Afaxys, Inc.
  • Merck and Co., Inc.
  • Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Method
  • Hormonals
  • Gender
  • End User
  • Region
Breakup by Method
  • Pills
  • Intrauterine Devices (IUD)
  • Injectables
  • Vaginal Ring
  • Implant
  • Patch
Breakup by Hormonals
  • Androgens
  • Estrogens
  • Progesterone
  • Antiandrogens
  • Gonadotrophins
  • Others
Breakup by Gender
  • Male
  • Female
Breakup by End User
  • Hospitals
  • Homecare
  • Clinics
  • Gynecology Centers
  • Ambulatory Surgical Centers (ASC)
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Allergan Inc.
  • Pfizer Inc.
  • Bayer AG
  • Afaxys, Inc.
  • Merck and Co., Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Reckitt Benckiser Group plc.
  • Boehringer Ingelheim International GmbH.
  • Agile Technologies
  • Warner Chilcott
  • Novartis AG
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

It is estimated that the global market for hormonal contraceptive will reach USD 17.49 billion by 2023.

The market is anticipated to grow at a CAGR of 4.1% during the forecast period of 2024-2032 to reach a value of USD 25.11 billion by 2032.

The major drivers of the industry, such as the rising consumer awareness regarding contraceptives, increased investment by the key players to develop improved solutions and formulations, favourable government policies to control population explosion, and growing demand for oral pills, are expected to aid the market growth.

The key market trends guiding the growth of the market include the growing shift towards family planning, increasing R&D activities, and rapid technological advancements.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

Pills, intrauterine devices (IUD), injectable, vaginal ring, implant, and patch, among others, are the major methods of hormonal contraceptive in the industry.

The major players in the industry are Allergan Inc., Pfizer Inc., Bayer AG, Afaxys, Inc., and Merck and Co., Inc., among others.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63 287899028, +63 967 048 3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124